Logo
T

Translumina Therapeutics

357 employees

Incorporated in 2010, Translumina is an interventional cardiovascular device company that delivers world-class products and services. Starting with direct imports and assembling of components, we are now a fully integrated product development and manufacturing company with facilities in Germany and India.

Investor insights

Funding rounds participated in

$70M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Device

Sectors

Medical Device

Date founded

2010

Funding rounds raised

Total raised

$70M

from 1 investors over 1 rounds

T

Translumina Therapeutics raised $70M on September 27, 2019

Investors: Everstone

FAQ